3rd Annual Biosimilars & Biobetters Congress
April 20 - 21, 2015 - London UKOxford Global
s.punfield@oxfordglobal.co.uk
Phone:+44 (0)1865 248455
Oxford Global’s 3rd Annual Biosimilars & Biobetters Congress is bringing together over 350 senior-level key opinion leaders working in the biologics sector. The conference program consists of two days: • Day 1 – Market Access Strategies, Opportunities And Commercial Challenges • Day 2 – Developing Biosimilars And Biobetters On day one delegates will hear presentations about the latest regulatory updates, global commercialisation strategies and biosimilars challenges & opportunities in emerging markets from representatives of Pfizer, Merck Serono and Baxter. Day two will focus on case studies demonstrating biosimilarity, overview of the insulin biosimilar market and the future of biosimilar and biobetter development. Delegates will meet representatives from well-known pharma companies such as Boehringer Ingelheim, MedImmune, Teva, Sanofi and many more. The Biosimilars Congress is co-located with our 8th Annual Proteins & Antibodies and 2nd Annual Peptides Congress. For further information on the Congress, or to enquire about available discounts and to register, please contact Steph Punfield on s.punfield@oxfordglobal.co.uk or call +44 (0)1865 248455.